首页> 外文期刊>Eye >Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice
【24h】

Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice

机译:在20年的玻璃体切除术中,糖尿病性增生性视网膜病在10年内的手术和视觉效果,为实践上的改变提供了证据

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction The study reports 10-year anatomical and visual outcome in patients who underwent pars plana vitrectomy (PPV) for complications due to proliferative diabetic retinopathy (PDR). Methods Retrospective analysis of patients undergoing 20G PPV from January 1999 to May 2010 for tractional retinal detachment (TRD) and non-clearing vitreous hemorrhage (NCVH) secondary to PDR recorded prospectively on an electronic patient record. The primary aim was to study anatomical success and eyes with visual acuity (VA) of ≤ 0.3 logMAR at last follow-up. Results There were 346 eyes of 249 patients with mean age of 55.63 years and follow-up of 1.44 years. In all, 95.3% of eyes had a flat retina at final follow-up. Overall 136/346 (39.4%) eyes had final VA of logMAR ≤ 0.3 (Snellen 6/12) and 129 (37.3%) had logMAR ≥ 1.0 (Snellen 6/60). In all, 50/181 (27.6%) eyes with TRD and 84/165 (50.9%) with NCVH achieved final VA of ≤ 0.3 logMAR (Snellen 6/12). A total of 218 (63.1%) showed ≥ 0.3 logMAR improvement from baseline to last follow-up. Both preoperative VA and final postoperative (post-op) VA (Po 0.001) improved significantly with each year from 1999 to 2010. The commonest peroperative complication was iatrogenic retinal tear formation (28.4%). This was a risk factor for the development of post-op retinal detachment, odds ratio: 3.90 (95% confidence interval: 1.91-7.97, P = 0.0002). Silicone oil was used in 5.2% of patients at the primary procedure. In all, 9.2% required removal of non clearing post vitrectomy hemorrhage. Conclusions Outcomes from vitreoretinal surgery for complications of diabetic retinopathy have improved. In addition, the visual outcome after diabetic vitrectomy steadily improved over the 10-year period, which may in part be due to the move to operate on patients with better vision.
机译:引言这项研究报告了因增生性糖尿病性视网膜病变(PDR)而进行了pars平板玻璃体切除术(PPV)的患者的10年解剖和视觉结果。方法回顾性分析从1999年1月至2010年5月在电子病历中前瞻性记录的因PDR继发的牵引性视网膜脱离(TRD)和非清除性玻璃体出血(NCVH)接受20G PPV的患者。主要目的是研究最后一次随访时的解剖学成功和视力(VA)≤0.3 logMAR的眼睛。结果249例患者中有346只眼,平均年龄55.63岁,随访1。44年。在最后一次随访中,总共有95.3%的眼睛具有平坦的视网膜。总体有136/346(39.4%)眼的最终视力达到logMAR≤0.3(Snellen 6/12),有129(37.3%)的logMAR≥1.0(Snellen 6/60)。总的来说,接受TRD的50/181(27.6%)眼和接受NCVH的84/165(50.9%)眼的最终VA≤0.3 logMAR(Snellen 6/12)。从基线到最后一次随访,共有218例(63.1%)显示≥0.3 logMAR改善。从1999年到2010年,术前VA和术后最​​终(术后)VA(Po 0.001)均有显着改善。术中最常见的并发症是医源性视网膜泪液形成(28.4%)。这是术后视网膜脱离发展的危险因素,比值比:3.90(95%置信区间:1.91-7.97,P = 0.0002)。在主要手术中,有5.2%的患者使用了硅油。总体而言,有9.2%的患者需要切除玻璃体切除术后的非清除性出血。结论玻璃体视网膜手术治疗糖尿病性视网膜病变的并发症有所改善。此外,糖尿病玻璃体切除术后的视觉效果在过去的10年中稳步提高,这可能部分是由于对视力更好的患者进行手术所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号